Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
19,314,982
-
Share change
-
-208,503
-
Total reported value
-
$241,658,115
-
Put/Call ratio
-
763%
-
Price per share
-
$12.51
-
Number of holders
-
94
-
Value change
-
-$3,019,434
-
Number of buys
-
49
-
Number of sells
-
27
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2020
As of 31 Dec 2020,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,314,982 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., Corriente Advisors, LLC, Slate Path Capital LP, VANGUARD GROUP INC, STATE STREET CORP, Prosight Management, LP, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, and Woodline Partners LP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.